Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans
Mark A. Cohen,
Sandra M. Ellis,
Carel W. Le Roux,
Rachel L. Batterham,
Adrian Park,
Michael Patterson,
Gary S. Frost,
Mohammad A. Ghatei and
Stephen R. Bloom
Departments of Metabolic Medicine (M.A.C., C.W.L.R., R.L.B., A.P., M.P., M.A.G., S.R.B.) and Dietetics (S.M.E., G.S.F.), Imperial College London, Hammersmith Hospital Campus, London, United Kingdom W12 0NN
Address all correspondence and requests for reprints to: Prof. Stephen R. Bloom, Department of Metabolic Medicine, Imperial College London at Hammersmith Campus, Du Cane Road, London, United Kingdom W12 0NN. E-mail: s.bloom{at}imperial.ac.uk.
Oxyntomodulin (OXM) is released from the gut postprandially,in proportion to energy intake, and circulating levels of OXMare elevated in several conditions associated with anorexia.Central injection of OXM reduces food intake and weight gainin rodents, suggesting that OXM signals food ingestion to hypothalamicappetite-regulating circuits. We investigated the effect ofiv OXM (3.0 pmol/kg·min) on appetite and food intakein 13 healthy subjects (body mass index, 22.5 ± 0.9 kg/m2)in a randomized, double-blind, placebo-controlled, cross-overstudy. Infusion of OXM significantly reduced ad libitum energyintake at a buffet meal (mean decrease, 19.3 ± 5.6%;P < 0.01) and caused a significant reduction in scores forhunger. In addition, cumulative 12-h energy intake was significantlyreduced by infusion of OXM (mean decrease, 11.3 ± 6.2%;P < 0.05). OXM did not cause nausea or affect food palatability.Preprandial levels of the appetite-stimulatory hormone, ghrelin,were significantly suppressed by OXM (mean reduction, 44 ±10% of postprandial decrease; P < 0.0001). Elevated levelsof endogenous OXM associated with disorders of the gastrointestinaltract may contribute to anorexia.
This work was supported by grants from the Medical ResearchCouncil, United Kingdom (to M.A.C.), and the Wellcome Trust(to C.L.R., R.L.B., and A.P.).
Abbreviations: GLP-1, Glucagon-like peptide-1; GLP-1R, glucagon-likepeptide-1 receptor; OLI, oxyntomodulin-like immunoreactivity;OXM, oxyntomodulin; PYY, peptide YY; VAS, visual analog scales.
This article has been cited by other articles:
C. L. Roth and T. Reinehr Roles of Gastrointestinal and Adipose Tissue Peptides in Childhood Obesity and Changes After Weight Loss Due to Lifestyle Intervention
Arch Pediatr Adolesc Med,
February 1, 2010;
164(2):
131 - 138.
[Abstract][Full Text][PDF]
A. E. Relling, J. L. Pate, C. K. Reynolds, and S. C. Loerch Effect of feed restriction and supplemental dietary fat on gut peptide and hypothalamic neuropeptide messenger ribonucleic acid concentrations in growing wethers
J Anim Sci,
February 1, 2010;
88(2):
737 - 748.
[Abstract][Full Text][PDF]
M. Patterson, K. G. Murphy, S. R. Patel, N. A. Patel, H. C. Greenwood, J. H. Cooke, D. Campbell, G. A. Bewick, M. A. Ghatei, and S. R. Bloom Hypothalamic Injection of Oxyntomodulin Suppresses Circulating Ghrelin-Like Immunoreactivity
Endocrinology,
August 1, 2009;
150(8):
3513 - 3520.
[Abstract][Full Text][PDF]
M. R. Druce, J. S. Minnion, B. C. T. Field, S. R. Patel, J. C. Shillito, M. Tilby, K. E. L. Beale, K. G. Murphy, M. A. Ghatei, and S. R. Bloom Investigation of Structure-Activity Relationships of Oxyntomodulin (Oxm) Using Oxm Analogs
Endocrinology,
April 1, 2009;
150(4):
1712 - 1722.
[Abstract][Full Text][PDF]
A. Maida, J. A. Lovshin, L. L. Baggio, and D. J. Drucker The Glucagon-Like Peptide-1 Receptor Agonist Oxyntomodulin Enhances {beta}-Cell Function but Does Not Inhibit Gastric Emptying in Mice
Endocrinology,
November 1, 2008;
149(11):
5670 - 5678.
[Abstract][Full Text][PDF]
S. C. Woods and D. A. D'Alessio Central Control of Body Weight and Appetite
J. Clin. Endocrinol. Metab.,
November 1, 2008;
93(11_Supplement_1):
s37 - s50.
[Abstract][Full Text][PDF]
V. E F Crowley Overview of human obesity and central mechanisms regulating energy homeostasis
Ann Clin Biochem,
May 1, 2008;
45(3):
245 - 255.
[Abstract][Full Text][PDF]
S. R. Bloom, F. P. Kuhajda, I. Laher, X. Pi-Sunyer, G. V. Ronnett, T. M.M. Tan, and D. S. Weigle The Obesity Epidemic: Pharmacological Challenges
Mol. Interv.,
April 1, 2008;
8(2):
82 - 98.
[Abstract][Full Text][PDF]
O. B. Chaudhri, K. Wynne, and S. R. Bloom Can Gut Hormones Control Appetite and Prevent Obesity?
Diabetes Care,
February 1, 2008;
31(Supplement_2):
S284 - S289.
[Abstract][Full Text][PDF]
J. D. Latshaw Daily Energy Intake of Broiler Chickens is Altered by Proximate Nutrient Content and Form of the Diet
Poult. Sci.,
January 1, 2008;
87(1):
89 - 95.
[Abstract][Full Text][PDF]
E. T. Parlevliet, A. C. Heijboer, J. P. Schroder-van der Elst, L. M. Havekes, J. A. Romijn, H. Pijl, and E. P. M. Corssmit Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet
Am J Physiol Endocrinol Metab,
January 1, 2008;
294(1):
E142 - E147.
[Abstract][Full Text][PDF]
P. A. M. Smeets, S. Vidarsdottir, C. de Graaf, A. Stafleu, M. J. P. van Osch, M. A. Viergever, H. Pijl, and J. van der Grond Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E754 - E758.
[Abstract][Full Text][PDF]
R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor beta-Arrestin Recruitment and Signaling through G{alpha}
J. Pharmacol. Exp. Ther.,
July 1, 2007;
322(1):
148 - 154.
[Abstract][Full Text][PDF]
G. L. Sowden, D. J. Drucker, D. Weinshenker, and S. J. Swoap Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2007;
292(2):
R962 - R970.
[Abstract][Full Text][PDF]
K. G. Murphy, W. S. Dhillo, and S. R. Bloom Gut Peptides in the Regulation of Food Intake and Energy Homeostasis
Endocr. Rev.,
December 1, 2006;
27(7):
719 - 727.
[Abstract][Full Text][PDF]
K. E. Foster-Schubert and D. E. Cummings Emerging Therapeutic Strategies for Obesity
Endocr. Rev.,
December 1, 2006;
27(7):
779 - 793.
[Abstract][Full Text][PDF]
G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update,
September 1, 2006;
12(5):
585 - 601.
[Abstract][Full Text][PDF]
O. Chaudhri, C. Small, and S. Bloom Gastrointestinal hormones regulating appetite
Phil Trans R Soc B,
July 29, 2006;
361(1471):
1187 - 1209.
[Abstract][Full Text][PDF]
S. C Woods, T. A Lutz, N. Geary, and W. Langhans Pancreatic signals controlling food intake; insulin, glucagon and amylin
Phil Trans R Soc B,
July 29, 2006;
361(1471):
1219 - 1235.
[Abstract][Full Text][PDF]
N. A. Tritos and E. G. Kokkotou The Physiology and Potential Clinical Applications of Ghrelin, a Novel Peptide Hormone
Mayo Clin. Proc.,
May 1, 2006;
81(5):
653 - 660.
[Abstract][Full Text][PDF]
M Druce and S R Bloom The regulation of appetite
Arch. Dis. Child.,
February 1, 2006;
91(2):
183 - 187.
[Abstract][Full Text][PDF]
N. M. Neary, C. J. Small, M. R. Druce, A. J. Park, S. M. Ellis, N. M. Semjonous, C. L. Dakin, K. Filipsson, F. Wang, A. S. Kent, et al. Peptide YY3-36 and Glucagon-Like Peptide-17-36 Inhibit Food Intake Additively
Endocrinology,
December 1, 2005;
146(12):
5120 - 5127.
[Abstract][Full Text][PDF]
E. M Sinclair and D. J. Drucker Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
Physiology,
October 1, 2005;
20(5):
357 - 365.
[Abstract][Full Text][PDF]
S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake
Physiol Rev,
October 1, 2005;
85(4):
1131 - 1158.
[Abstract][Full Text][PDF]
K. Wynne, A. J. Park, C. J. Small, M. Patterson, S. M. Ellis, K. G. Murphy, A. M. Wren, G. S. Frost, K. Meeran, M. A. Ghatei, et al. Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects: A Double-Blind, Randomized, Controlled Trial
Diabetes,
August 1, 2005;
54(8):
2390 - 2395.
[Abstract][Full Text][PDF]
M. K. Badman and J. S. Flier The Gut and Energy Balance: Visceral Allies in the Obesity Wars
Science,
March 25, 2005;
307(5717):
1909 - 1914.
[Abstract][Full Text][PDF]
K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control
J. Endocrinol.,
February 1, 2005;
184(2):
291 - 318.
[Abstract][Full Text][PDF]
C. W. le Roux and S. R. Bloom Why Do Patients Lose Weight after Roux-en-Y Gastric Bypass?
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
591 - 592.
[Full Text][PDF]
K.G. Murphy and S.R. Bloom Gut hormones in the control of appetite
Exp Physiol,
September 1, 2004;
89(5):
507 - 516.
[Abstract][Full Text][PDF]
J. J. Holst and J. Gromada Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
Am J Physiol Endocrinol Metab,
August 1, 2004;
287(2):
E199 - E206.
[Abstract][Full Text][PDF]
K. Wynne, S. Stanley, and S. Bloom The Gut and Regulation of Body Weight
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2576 - 2582.
[Abstract][Full Text][PDF]
J. Korner and L. J. Aronne Pharmacological Approaches to Weight Reduction: Therapeutic Targets
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2616 - 2621.
[Full Text][PDF]
C. L. Dakin, C. J. Small, R. L. Batterham, N. M. Neary, M. A. Cohen, M. Patterson, M. A. Ghatei, and S. R. Bloom Peripheral Oxyntomodulin Reduces Food Intake and Body Weight Gain in Rats
Endocrinology,
June 1, 2004;
145(6):
2687 - 2695.
[Abstract][Full Text][PDF]
M. R. Druce, C. J. Small, and S. R. Bloom Minireview: Gut Peptides Regulating Satiety
Endocrinology,
June 1, 2004;
145(6):
2660 - 2665.
[Abstract][Full Text][PDF]
F. Broglio, C. Gottero, P. Van Koetsveld, F. Prodam, S. Destefanis, A. Benso, C. Gauna, L. Hofland, E. Arvat, A. J. van der Lely, et al. Acetylcholine Regulates Ghrelin Secretion in Humans
J. Clin. Endocrinol. Metab.,
May 1, 2004;
89(5):
2429 - 2433.
[Abstract][Full Text][PDF]
S. Stanley, K. Wynne, and S. Bloom Gastrointestinal Satiety Signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide
Am J Physiol Gastrointest Liver Physiol,
May 1, 2004;
286(5):
G693 - G697.
[Abstract][Full Text][PDF]